(PharmaNewsWire.Com, June 08, 2017 ) In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is very essential in drug discovery as identifies the toxic effects of new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.
Asia-Pacific in-vitro toxicology testing market is expected to reach USD 5.23 billion by 2021 from USD 2.48 billion in 2016, growing at a CAGR of 16.10% for the next five years 2016-2021.
Increasing demand for advanced toxicity testing methods, rising investments in research, growing healthcare infrastructure, and increasing government initiatives to enhance research in academics & private organizations to promote technologies are driving the growth of in-vitro toxicology testing market in Asia-Pacific region. However, high cost of the toxicology testing technologies & procedures and low adoption of advanced toxicology testing procedures are restraining the growth of Asia-Pacific in-vitro toxicology testing market.
Asia-Pacific in-vitro toxicology testing market is segmented based on the product, type, toxicity endpoints & tests, technology, method, and industry. Based on product, the market is further sub-segmented as assays, reagent & labware, and service. Assays segment is estimated to command the largest share of Asia-Pacific in-vitro toxicology testing market by product in 2016. Based on type, the market is segmented as ADME, dose, and toxic substance.
Toxicity endpoints & tests is further segmented as systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity. Systemic toxicity is estimated to command the largest share of Asia-Pacific in-vitro toxicology testing market by toxicity endpoints & tests in 2016. Technology is further segmented as OMICS technologies & cell culture technology.
By method, the market is segmented as in-silico method, biochemical assays, cellular assays, and ex vivo models. In-silico method is estimated to command the largest share of Asia-Pacific in-vitro toxicology testing market by method in 2016. The market, by industry, is sub-segmented as cosmetics & household products, pharmaceutical, diagnostics, chemical, & food. The cosmetics & household products industry is estimated to account for the largest market share of Asia-Pacific in-vitro toxicology testing market by industry in 2016.
On the basis of geographical areas, Asia-Pacific in-vitro toxicology testing market is segmented as Japan, China, and India. Japan is estimated to account for the largest share of the Asia-Pacific in-vitro toxicology testing market in 2016, whereas India is estimated to grow at the highest CAGR during the forecast period 2016-2021.
The key players in in-vitro toxicology testing market include, Covance, Inc. (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.), among others.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
